1. Home
  2. VYNE vs FTCI Comparison

VYNE vs FTCI Comparison

Compare VYNE & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • FTCI
  • Stock Information
  • Founded
  • VYNE 2003
  • FTCI 2017
  • Country
  • VYNE United States
  • FTCI United States
  • Employees
  • VYNE N/A
  • FTCI N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • FTCI Semiconductors
  • Sector
  • VYNE Health Care
  • FTCI Technology
  • Exchange
  • VYNE Nasdaq
  • FTCI Nasdaq
  • Market Cap
  • VYNE 35.7M
  • FTCI 32.6M
  • IPO Year
  • VYNE 2018
  • FTCI 2021
  • Fundamental
  • Price
  • VYNE $1.33
  • FTCI $3.35
  • Analyst Decision
  • VYNE Strong Buy
  • FTCI Buy
  • Analyst Count
  • VYNE 2
  • FTCI 4
  • Target Price
  • VYNE $6.25
  • FTCI $5.50
  • AVG Volume (30 Days)
  • VYNE 223.6K
  • FTCI 66.5K
  • Earning Date
  • VYNE 05-08-2025
  • FTCI 05-01-2025
  • Dividend Yield
  • VYNE N/A
  • FTCI N/A
  • EPS Growth
  • VYNE N/A
  • FTCI N/A
  • EPS
  • VYNE N/A
  • FTCI N/A
  • Revenue
  • VYNE $605,000.00
  • FTCI $55,571,000.00
  • Revenue This Year
  • VYNE N/A
  • FTCI $107.93
  • Revenue Next Year
  • VYNE N/A
  • FTCI $121.09
  • P/E Ratio
  • VYNE N/A
  • FTCI N/A
  • Revenue Growth
  • VYNE 18.16
  • FTCI N/A
  • 52 Week Low
  • VYNE $1.27
  • FTCI $1.76
  • 52 Week High
  • VYNE $4.30
  • FTCI $7.40
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 33.79
  • FTCI 58.30
  • Support Level
  • VYNE $1.27
  • FTCI $2.90
  • Resistance Level
  • VYNE $1.41
  • FTCI $3.63
  • Average True Range (ATR)
  • VYNE 0.11
  • FTCI 0.29
  • MACD
  • VYNE -0.02
  • FTCI 0.02
  • Stochastic Oscillator
  • VYNE 0.00
  • FTCI 66.34

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

Share on Social Networks: